http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201713342-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate | 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14e1a292139819481d9ba093fc64bdc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f79a5af60a7680fa1131ed95b8b1716 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c6c6f45753d31046b41a27520eeb456 |
| publicationDate | 2017-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201713342-A |
| titleOfInvention | Medicinal composition using pyrazine carboxamide compound as an active ingredient |
| abstract | Provided is a pharmaceutical composition for treating a cancer associated with BMX, particularly a therapeutic pharmaceutical composition for prostate cancer, bladder cancer, and/or renal cell carcinoma.nThe inventors of the present invention have studied a compound having a BMX inhibitory action, and confirmed that a specific pyrazine carboxamide compound has a BMX inhibitory action, and a pharmaceutical composition containing such a compound as an active ingredient for a BMX-related cancer, particularly prostate cancer, Bladder cancer and/or renal cell carcinoma have therapeutic effects, and the present invention has been completed. |
| priorityDate | 2015-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.